Clinical Trial Update: Alternate Donor Study of Pre-Emptive Cellular Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for pre-emptive cellular therapy using alternate donors in cytomegalovirus infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Snippet

Sponsor: Cell Medica Ltd | Conditions: Cytomegalovirus Infection | Phase 2 | Status: COMPLETED